Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity

M Skovbro, M Baranowski, C Skov-Jensen, A Flint, F Dela, J Gorski, J W Helge

Research output: Contribution to journalJournal articleResearchpeer-review

110 Citations (Scopus)

Abstract

AIMS/HYPOTHESIS: In skeletal muscle, ceramides may be involved in the pathogenesis of insulin resistance through an attenuation of insulin signalling. This study investigated total skeletal muscle ceramide fatty acid content in participants exhibiting a wide range of insulin sensitivities. METHODS: The middle-aged male participants (n=33) were matched for lean body mass and divided into four groups: type 2 diabetes (T2D, n=8), impaired glucose tolerance (IGT, n=9), healthy controls (CON, n=8) and endurance-trained (TR, n=8). A two step (28 and 80 mU m(-2) min(-1)) sequential euglycaemic-hyperinsulinaemic clamp was performed for 120 and 90 min for step 1 and step 2, respectively. Muscle biopsies were obtained from vastus lateralis at baseline, and after steps 1 and 2. RESULTS: Glucose infusion rates increased in response to insulin infusion, and significant differences were present between groups (T2D
Original languageEnglish
JournalDiabetologia
Volume51
Issue number7
Pages (from-to)1253-60
Number of pages7
ISSN0012-186X
DOIs
Publication statusPublished - 2008

Bibliographical note

Keywords: Biopsy; Blood Glucose; Ceramides; Diabetes Mellitus, Type 2; Diglycerides; Glucose Clamp Technique; Glucose Intolerance; Humans; Hyperinsulinism; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Oxygen Consumption; Physical Endurance; Triglycerides

Cite this